Logotype for Integrated Diagnostics Holdings plc

Integrated Diagnostics (IDHC) H2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Integrated Diagnostics Holdings plc

H2 2025 earnings summary

28 Apr, 2026

Executive summary

  • Achieved 37% year-over-year revenue growth in FY 2025, reaching EGP 7.9 billion, with strong expansion across Egypt, Jordan, Nigeria, and Saudi Arabia, and progress on strategic priorities including network expansion, service diversification, and digitalization.

  • Adjusted net profit rose 79% year-over-year to EGP 1,262 million, with margin expansion at all profitability levels and sustained improvements in scalability.

  • Test volumes increased 11% year-over-year to 43.5 million, and average revenue per test rose 24%.

  • Strategic price increases and cost optimization drove margin improvements, supported by easing inflation and currency stabilization in key markets.

  • Strengthened leadership in Egypt and Jordan, with encouraging progress in Nigeria and Saudi Arabia.

Financial highlights

  • Revenue grew 37% year-over-year to EGP 7.9 billion, driven by both volume (+11%) and value (+24% average revenue per test).

  • EBITDA margin expanded to 35% from 30% last year; gross profit margin rose to 43% from 38%.

  • Adjusted net profit increased 79% year-over-year to EGP 1,262 million; reported net profit reached EGP 1.3 billion, up 29%.

  • Board declared a dividend of $0.0085 per share, totaling $4.9 million.

  • FY 2025 CAPEX totaled EGP 790 million (10% of revenue), including expansion and acquisitions.

Outlook and guidance

  • FY 2026 consolidated revenue expected to grow 39% year-over-year; guidance targets 25% sales growth, with 10% from price increases and 15% from volume; EBITDA margin expected at 33%-34%.

  • Targeting 200 new branch openings in 2026 across Egypt, Saudi Arabia, and Jordan, including clinics and hospitals.

  • Saudi Arabia revenue target for 2026 is SAR 18 million; EBITDA break-even expected by 2028.

  • CapEx forecast for 2026 is 5.9% of total sales, mainly allocated to Egypt.

  • Focus remains on Saudi Arabia ramp-up, volume growth in Jordan and Nigeria, and continued margin improvement through digitalization and cost management.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more